Cencora (NYSE:COR – Get Free Report) was upgraded by equities researchers at Wall Street Zen from a “hold” rating to a “buy” rating in a research report issued on Saturday.

Several other equities research analysts have also recently issued reports on the stock. Wells Fargo & Company decreased their price target on shares of Cencora from $429.00 to $331.00 and set an “overweight” rating on the stock in a research note on Monday, May 11th. Robert W. Baird set a $370.00 price objective on shares of Cencora in a research report on Thursday. Bank of America boosted their price objective on shares of Cencora from $280.00 to $285.00 and gave the company a “neutral” rating in a research report on Wednesday, June 24th. JPMorgan Chase & Co. upped their price objective on shares of Cencora from $382.00 to $390.00 and gave the company an “overweight” rating in a research note on Friday. Finally, UBS Group raised their target price on shares of Cencora from $412.00 to $430.00 and gave the stock a “buy” rating in a research report on Thursday. Thirteen analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $368.92.

Check Out Our Latest Analysis on Cencora

Cencora stock opened at $320.62 on Friday. Cencora has a fifty-two week low of $244.82 and a fifty-two week high of $377.54. The company has a market capitalization of $62.38 billion, a price-to-earnings ratio of 23.82, a PEG ratio of 1.84 and a beta of 0.57. The stock has a fifty day moving average of $293.89 and a two-hundred day moving average of $314.13. The company has a debt-to-equity ratio of 3.53, a quick ratio of 0.58 and a current ratio of 0.93.

Cencora (NYSE:COR – Get Free Report) last issued its quarterly earnings data on Wednesday, August 5th. The company reported $4.48 earnings per share (EPS) for the quarter, beating the consensus estimate of $4.35 by $0.13. The business had revenue of $84.75 billion for the quarter, compared to the consensus estimate of $84.31 billion. Cencora had a return on equity of 125.45% and a net margin of 0.79%.The business’s revenue was up 5.1% on a year-over-year basis. During the same period in the prior year, the business earned $4.00 earnings per share. On average, analysts anticipate that Cencora will post 17.83 EPS for the current fiscal year.

Cencora announced that its board has initiated a stock buyback program on Thursday, May 21st that authorizes the company to repurchase $2.00 billion in outstanding shares. This repurchase authorization authorizes the company to repurchase up to 3.9% of its shares through open market purchases. Shares repurchase programs are usually a sign that the company’s board believes its shares are undervalued.

In related news, Director Lauren M. Tyler purchased 550 shares of the company’s stock in a transaction that occurred on Monday, June 22nd. The stock was purchased at an average price of $270.23 per share, with a total value of $148,626.50. Following the completion of the transaction, the director owned 4,359 shares of the company’s stock, valued at approximately $1,177,932.57. This trade represents a 14.44% increase in their position. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Company insiders own 0.38% of the company’s stock.

A number of hedge funds have recently made changes to their positions in COR. Apollon Wealth Management LLC grew its holdings in shares of Cencora by 0.5% during the fourth quarter. Apollon Wealth Management LLC now owns 6,527 shares of the company’s stock valued at $2,205,000 after purchasing an additional 30 shares during the last quarter. Accent Capital Management LLC lifted its holdings in shares of Cencora by 36.1% in the 4th quarter. Accent Capital Management LLC now owns 113 shares of the company’s stock worth $38,000 after purchasing an additional 30 shares during the last quarter. MCF Advisors LLC lifted its holdings in shares of Cencora by 11.0% in the 4th quarter. MCF Advisors LLC now owns 303 shares of the company’s stock worth $102,000 after purchasing an additional 30 shares during the last quarter. CYBER HORNET ETFs LLC lifted its holdings in shares of Cencora by 6.8% in the 4th quarter. CYBER HORNET ETFs LLC now owns 485 shares of the company’s stock worth $164,000 after purchasing an additional 31 shares during the last quarter. Finally, Steph & Co. boosted its position in Cencora by 23.5% during the 1st quarter. Steph & Co. now owns 168 shares of the company’s stock valued at $53,000 after purchasing an additional 32 shares during the period. Institutional investors and hedge funds own 97.52% of the company’s stock.

(Get Free Report)

Cencora (NYSE:COR) is a global healthcare services and pharmaceutical distribution company that provides end-to-end solutions across the pharmaceutical supply chain. The company’s core activities include wholesale drug distribution, specialty drug distribution, and the operation of specialty pharmacies, complemented by logistics, cold-chain management and other fulfillment services designed to support complex and temperature-sensitive therapies.

Beyond physical distribution, Cencora offers a range of commercial and patient-focused services for pharmaceutical manufacturers and healthcare providers.

• Five stocks we like better than Cencora
• Albemarle’s Blowout Quarter Shows Why Lithium Still Matters
• Can DICK’S Turn Foot Locker Into a Winner?
• Why Dutch Bros Plunged Despite a Q2 Earnings Beat and Record Revenue
• Take-Two’s Q1 Results Leave GTA 6 Bulls Stuck in the Fog of War

Receive News & Ratings for Cencora Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cencora and related companies with MarketBeat.com's FREE daily email newsletter.

Wall Street Zen Upgrades BlueLinx (NYSE:BXC) to “Buy”

Wall Street Zen Upgrades Upstart (NASDAQ:UPST) to “Hold”